While Europe is concerned about Astrazeneca's Covid-19 vaccine, many countries around the world still have expectations to escape pandemic.

In the early stages of pandemic, Vaccine Covid-19 collaborated by the UK Pharmaceutical Company - Sweden Astrazeneca developed with Oxford University to be largely expected and promoted, thanks to rapid growth rate and technology

Now, the more successful public doubts of Astrazeneca's vaccine, related to the blood clotting after injecting in many European countries.

EMA on April 7 concluded the occurrence of abnormal blood clots with low blood platelets should be listed as "very rare side effects" of Astrazeneca vaccine, but arguing that countries should continue to use

Medical staff prepared a Dose of Astrazeneca's Covid-19 vaccine in Sidcup, southeast London, England, on January 7.

Denmark and Norway have suspended using Astrazeneca vaccine, while Italy recommends only this vaccine to people over 60 years old, similar to Spain's recent moves.

Even the British government, the country has praised the role of Oxford University in the development of vaccines, also indicates that adults under 30 years of age should be injected with other vaccines, after British pharmaceutical management agency MHRA determined

The polls show that many Europeans now consider the Astrazeneca vaccine "unsafe".

However, while Europe faltered, many countries around the world still looked forward to the Astrazeneca vaccine.

Unlike many other Covid-19 vaccines, Astrazeneca's vaccine is quite cheap and easy to use.

According to the study published last month of the Think Global Health Program in the Council of Foreign Relations Council Advisors, Astrazeneca vaccine is expected to account for nearly 50% of global vaccines in low-average middle-income countries, and occupy 1

Even so, export control status is becoming a big challenge.

Najwa Mekki, the United Nations Children's Fund spokesman (UNICEF), last week, said Covax now received 28 million doses of Astrazeneca vaccine from the Indian Serum Institute, of a total of 90 million doses they expected to receive in

Export activities are expected to return to normal in May. However, the CEO of Adar Serum Institute Poonawalla is not optimistic, when it comes that exporting may not fully recover until June,

"We will have to maintain supply for India, not anywhere else, because we have to protect our country," Poonawalla said.

John Nkegasong, director of the African Disease Control and Prevention Center, said the loss of Astrazeneca vaccines may become "disaster" for this continent's vaccination route.

India is not the only country to limit vaccine exports.

The US also sets strict restrictions on vaccine exports.

Andrea Taylor, researcher at Duke University of the United States, explained that one reason for India's export control orders so a great influence is because New Delhi's decision is given suddenly.

"The United States can play an important role in supporting the world to approach the vaccine, but they have never planned that plan, at least not in 2021. It is because of their nation's starting point

With the American vaccination program, it is thought to be smooth despite the Astrazeneca vaccine, Dr. Anthony Fauci, a medical advisor of US President Joe Biden, last week, "still unknown" they have a vaccine

However, with the rest of the world, the Astrazeneca vaccine is probably still desirable, existing in parallel with the mood of the safety level.